KIMBERLY WRIGHT: Open Payments
NPI 1154085074 · MT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 23 payments from 11 companies in 2025. Trend: 2023 $61 · 2024 $29 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $167 |
| Novo Nordisk Inc | 4 | $94 |
| Alkermes, Inc. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| ABBVIE INC. | 2 | $37 |
| Indivior Inc. | 2 | $34 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| PFIZER INC. | 1 | $18 |
Products named: MOUNJARO, ARISTADA, REXULTI, Rybelsus, SUBLOCADE, Quviviq, Auvelity, Symbravo.
Industry payments across SC — which companies pay providers there.
